Understanding U.S. Customs Valuation in the Biopharma and Life Sciences Industry

About The Webinar

Biopharma and life sciences companies face unique challenges when valuing their research and development, clinical, commercial, and compassionate use products for cross-border transactions. These valuation decisions - which can have significant impacts on the amount of duties and tariffs owed, particularly in today’s volatile trade policy environment - must also comply with U.S. customs and tax laws while complementing the company’s business and tax strategies.

Every day, these companies enter into development and supply agreements, license technologies, sign royalty agreements, and source necessary materials to create innovative therapies. What often complicates these transactions is whether their value or cost must be added to the declared value of imported materials or products. This webinar provides an overview of basic U.S. customs law valuation principles and highlights specific areas relevant to the biopharma and life sciences industry.

Please note webinars are hosted by World Trade Interactive, Inc. Payments for our webinars will appear as World Trade Interactive, Inc. on your statement.

Contact webinarorganizers@strtrade.com if you have issues registering. Please note we do not take American Express